Anti-LYNX1 monoclonal antibody

Anti-LYNX1 antibody for FACS & in-vivo assay

Target products collectionGo to LYNX1/LYNX1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0781-Ab-1/ GM-Tg-hg-MP0781-Ab-2Anti-Human LYNX1 monoclonal antibodyHuman
GM-Tg-rg-MP0781-Ab-1/ GM-Tg-rg-MP0781-Ab-2Anti-Rat LYNX1 monoclonal antibodyRat
GM-Tg-mg-MP0781-Ab-1/ GM-Tg-mg-MP0781-Ab-2Anti-Mouse LYNX1 monoclonal antibodyMouse
GM-Tg-cynog-MP0781-Ab-1/ GM-Tg-cynog-MP0781-Ab-2Anti-Cynomolgus/ Rhesus macaque LYNX1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0781-Ab-1/ GM-Tg-felg-MP0781-Ab-2Anti-Feline LYNX1 monoclonal antibodyFeline
GM-Tg-cang-MP0781-Ab-1/ GM-Tg-cang-MP0781-Ab-2Anti-Canine LYNX1 monoclonal antibodyCanine
GM-Tg-bovg-MP0781-Ab-1/ GM-Tg-bovg-MP0781-Ab-2Anti-Bovine LYNX1 monoclonal antibodyBovine
GM-Tg-equg-MP0781-Ab-1/ GM-Tg-equg-MP0781-Ab-2Anti-Equine LYNX1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0781-Ab-1/ GM-Tg-hg-MP0781-Ab-2; GM-Tg-rg-MP0781-Ab-1/ GM-Tg-rg-MP0781-Ab-2;
GM-Tg-mg-MP0781-Ab-1/ GM-Tg-mg-MP0781-Ab-2; GM-Tg-cynog-MP0781-Ab-1/ GM-Tg-cynog-MP0781-Ab-2;
GM-Tg-felg-MP0781-Ab-1/ GM-Tg-felg-MP0781-Ab-2; GM-Tg-cang-MP0781-Ab-1/ GM-Tg-cang-MP0781-Ab-2;
GM-Tg-bovg-MP0781-Ab-1/ GM-Tg-bovg-MP0781-Ab-2; GM-Tg-equg-MP0781-Ab-1/ GM-Tg-equg-MP0781-Ab-2
Products NameAnti-LYNX1 monoclonal antibody
Formatmab
Target NameLYNX1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LYNX1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species LYNX1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP004856human LYNX1 Lentivirus plasmid
    ORF Viral VectorvGMLP004856human LYNX1 Lentivirus particle
    ORF Viral VectorpGMLPm000301mouse Lynx1 Lentivirus plasmid
    ORF Viral VectorvGMLPm000301mouse Lynx1 Lentivirus particle


    Target information

    Target IDGM-MP0781
    Target NameLYNX1
    Gene ID66004,23936,300018,574359,100066475
    Gene Symbol and SynonymsLYNX1,SLURP-2
    Uniprot AccessionP0DP58,P0DP61,P0DP62
    Uniprot Entry NameLYNX1_HUMAN,SLUR2_MACMU,LYNX1_MACMU
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000180155
    Target ClassificationN/A

    The target: LYNX1, gene name: LYNX1, also named as . This gene encodes a GPI-anchored, cell membrane bound member of the Ly6/uPAR (LU) superfamily of proteins containing the unique three-finger LU domain. This protein interacts with nicotinic acetylcholine receptors (nAChRs), and is thought to function as a modulator of nAChR activity to prevent excessive excitation. Alternatively spliced transcript variants have been found for this gene. Read-through transcription between this gene and the neighboring downstream gene (SLURP2) generates naturally-occurring transcripts (LYNX1-SLURP2) that encode a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Sep 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.